Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred

(CAG)n expansion and early premonitory signs and symptoms

D. Genis, T. Matilla, V. Volpini, J. Rosell, A. Dávalos, I. Ferrer, A. Molins, Xavier P. Estivill

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

We report the clinical, neuropathologic, and genetic studies of a large kindred (family M-ADCA1) with autosomal dominant spinocerebellar ataxia type 1 (SCA1), ascertained in 41 members, with clinical data available in twenty-two. The mean age of onset was 36.3 ± 6.2 years (ages, 26 to 52), the mean duration of the disease was 15.8 ± 6.5 years (range, 10 to 28 years), and the mean age at death was 54.1 ± 9.5 years (ages, 39 to 72). Premonitory signs and symptoms appeared earlier than the usual onset symptoms in many of the clinically unaffected patients who inherited the mutated SCA1 gene. Anticipation was present when we compared the seventh and eighth generations. A more severe course of the disease occurred in offspring of affected males. Neuropathologic examination, performed on three patients, showed the usual findings of SCA1; Golgi and immunocytochemistry studies suggested primary damage of the Purkinje cells. We analyzed the CAG-repeat mutation responsible for the SCA1 phenotype in a total of 41 family members. There was expansion in 19 subjects (10 clinically affected, seven with early signs and symptoms, and two asymptomatic individuals), and all showed heterozygosity, with one allele between 41 and 59 repeats (SCA1 mutation) and the other in the range of 6 to 39 repeats (normal range). The clinical analysis of "at risk" patients with the SCA1 mutation showed that minor signs and symptoms begin before full clinical diagnosis, and these premonitory manifestations can herald full development of SCA1 by years.

Original languageEnglish
Pages (from-to)24-30
Number of pages7
JournalNeurology
Volume45
Issue number1
Publication statusPublished - Jan 1995
Externally publishedYes

Fingerprint

Spinocerebellar Ataxias
Signs and Symptoms
Mutation
Purkinje Cells
Age of Onset
Reference Values
Repeats
Immunohistochemistry
Alleles
Phenotype
Onset

ASJC Scopus subject areas

  • Neuroscience(all)
  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred : (CAG)n expansion and early premonitory signs and symptoms. / Genis, D.; Matilla, T.; Volpini, V.; Rosell, J.; Dávalos, A.; Ferrer, I.; Molins, A.; Estivill, Xavier P.

In: Neurology, Vol. 45, No. 1, 01.1995, p. 24-30.

Research output: Contribution to journalArticle

Genis, D. ; Matilla, T. ; Volpini, V. ; Rosell, J. ; Dávalos, A. ; Ferrer, I. ; Molins, A. ; Estivill, Xavier P. / Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred : (CAG)n expansion and early premonitory signs and symptoms. In: Neurology. 1995 ; Vol. 45, No. 1. pp. 24-30.
@article{015415077b35460986daf2f2dc1edcf8,
title = "Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms",
abstract = "We report the clinical, neuropathologic, and genetic studies of a large kindred (family M-ADCA1) with autosomal dominant spinocerebellar ataxia type 1 (SCA1), ascertained in 41 members, with clinical data available in twenty-two. The mean age of onset was 36.3 ± 6.2 years (ages, 26 to 52), the mean duration of the disease was 15.8 ± 6.5 years (range, 10 to 28 years), and the mean age at death was 54.1 ± 9.5 years (ages, 39 to 72). Premonitory signs and symptoms appeared earlier than the usual onset symptoms in many of the clinically unaffected patients who inherited the mutated SCA1 gene. Anticipation was present when we compared the seventh and eighth generations. A more severe course of the disease occurred in offspring of affected males. Neuropathologic examination, performed on three patients, showed the usual findings of SCA1; Golgi and immunocytochemistry studies suggested primary damage of the Purkinje cells. We analyzed the CAG-repeat mutation responsible for the SCA1 phenotype in a total of 41 family members. There was expansion in 19 subjects (10 clinically affected, seven with early signs and symptoms, and two asymptomatic individuals), and all showed heterozygosity, with one allele between 41 and 59 repeats (SCA1 mutation) and the other in the range of 6 to 39 repeats (normal range). The clinical analysis of {"}at risk{"} patients with the SCA1 mutation showed that minor signs and symptoms begin before full clinical diagnosis, and these premonitory manifestations can herald full development of SCA1 by years.",
author = "D. Genis and T. Matilla and V. Volpini and J. Rosell and A. D{\'a}valos and I. Ferrer and A. Molins and Estivill, {Xavier P.}",
year = "1995",
month = "1",
language = "English",
volume = "45",
pages = "24--30",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred

T2 - (CAG)n expansion and early premonitory signs and symptoms

AU - Genis, D.

AU - Matilla, T.

AU - Volpini, V.

AU - Rosell, J.

AU - Dávalos, A.

AU - Ferrer, I.

AU - Molins, A.

AU - Estivill, Xavier P.

PY - 1995/1

Y1 - 1995/1

N2 - We report the clinical, neuropathologic, and genetic studies of a large kindred (family M-ADCA1) with autosomal dominant spinocerebellar ataxia type 1 (SCA1), ascertained in 41 members, with clinical data available in twenty-two. The mean age of onset was 36.3 ± 6.2 years (ages, 26 to 52), the mean duration of the disease was 15.8 ± 6.5 years (range, 10 to 28 years), and the mean age at death was 54.1 ± 9.5 years (ages, 39 to 72). Premonitory signs and symptoms appeared earlier than the usual onset symptoms in many of the clinically unaffected patients who inherited the mutated SCA1 gene. Anticipation was present when we compared the seventh and eighth generations. A more severe course of the disease occurred in offspring of affected males. Neuropathologic examination, performed on three patients, showed the usual findings of SCA1; Golgi and immunocytochemistry studies suggested primary damage of the Purkinje cells. We analyzed the CAG-repeat mutation responsible for the SCA1 phenotype in a total of 41 family members. There was expansion in 19 subjects (10 clinically affected, seven with early signs and symptoms, and two asymptomatic individuals), and all showed heterozygosity, with one allele between 41 and 59 repeats (SCA1 mutation) and the other in the range of 6 to 39 repeats (normal range). The clinical analysis of "at risk" patients with the SCA1 mutation showed that minor signs and symptoms begin before full clinical diagnosis, and these premonitory manifestations can herald full development of SCA1 by years.

AB - We report the clinical, neuropathologic, and genetic studies of a large kindred (family M-ADCA1) with autosomal dominant spinocerebellar ataxia type 1 (SCA1), ascertained in 41 members, with clinical data available in twenty-two. The mean age of onset was 36.3 ± 6.2 years (ages, 26 to 52), the mean duration of the disease was 15.8 ± 6.5 years (range, 10 to 28 years), and the mean age at death was 54.1 ± 9.5 years (ages, 39 to 72). Premonitory signs and symptoms appeared earlier than the usual onset symptoms in many of the clinically unaffected patients who inherited the mutated SCA1 gene. Anticipation was present when we compared the seventh and eighth generations. A more severe course of the disease occurred in offspring of affected males. Neuropathologic examination, performed on three patients, showed the usual findings of SCA1; Golgi and immunocytochemistry studies suggested primary damage of the Purkinje cells. We analyzed the CAG-repeat mutation responsible for the SCA1 phenotype in a total of 41 family members. There was expansion in 19 subjects (10 clinically affected, seven with early signs and symptoms, and two asymptomatic individuals), and all showed heterozygosity, with one allele between 41 and 59 repeats (SCA1 mutation) and the other in the range of 6 to 39 repeats (normal range). The clinical analysis of "at risk" patients with the SCA1 mutation showed that minor signs and symptoms begin before full clinical diagnosis, and these premonitory manifestations can herald full development of SCA1 by years.

UR - http://www.scopus.com/inward/record.url?scp=0028819081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028819081&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 24

EP - 30

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 1

ER -